This page has been updated recently.
- February 6, 2017 Approval Letter - Gammaplex 5% & 10% (PDF - 46KB)
- Public Workshop: Identification and Characterization of the Infectious Disease Risks of Human Cells, Tissues, and Cellular and Tissue-based Products Speaker Biographies
- The 20th US-Japan Cellular and Gene Therapy Conference
- Complete List of Currently Approved NDA and ANDA Application Submissions (PDF - 22KB)
Posted: 2/7/2017; updated through 1/31/2017